Señales en vivo de TYRA | Maximiza tus Ganancias con Getagraph.com

COMPRAR 111396 min ago

@ $19.02

Emitido: 12 feb 2024 @ 12:36

Retorno: -13.51%

Señal anterior: feb 12 - 09:39

Señal anterior: Vender

Retorno: -0.94 %

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 16:00):

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer...

Stats
Volumen de hoy	115 945
Volumen promedio	146 504
Capitalización de mercado	864.02M
EPS	$0 ( 2024-03-27 )
Próxima fecha de ganancias	( $-0.460 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.15
ATR14	$0.0240 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Fuhrman Alan	Buy	932	Common Stock
2024-03-15	Tada Hiroomi	Buy	1 968	Common Stock
2024-03-15	Harris Todd	Buy	1 880	Common Stock
2024-03-11	Bensen Daniel	Sell	200	Common Stock
2024-03-06	Bensen Daniel	Sell	1 733	Common Stock

INSIDER POWER
85.25
Last 100 transactions
Buy: 6 273 982 \| Sell: 603 690

Volumen Correlación

Largo: 0.05 (neutral)

Corto: 0.47 (neutral)

Signal:(50.964) Neutral

Tyra Biosciences, Inc. Correlación

10 Correlaciones Más Positivas
DRNA	0.954
SUMO	0.939
IOAC	0.936
OCSL	0.935
IRMD	0.932
CMPI	0.922
XM	0.921
ALBO	0.92
SLMBP	0.919
PRAA	0.915

10 Correlaciones Más Negativas
GMII	-0.933
WASH	-0.921
AFYA	-0.913
EAR	-0.897
TRMK	-0.897
XPDI	-0.894
GOOD	-0.893
ALXO	-0.888
TUEM	-0.888
AVIR	-0.884

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tyra Biosciences, Inc. Correlación - Moneda/Commodity

-0.06
( neutral )

-0.57
( weak negative )

0.00
( neutral )

-0.65
( moderate negative )

0.80
( moderate )

0.15
( neutral )

Tyra Biosciences, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-353 000 (0.00 %)
EPS:	$-1.620

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-353 000 (0.00 %)
EPS:	$-1.620

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-296 000 (0.00 %)
EPS:	$-1.230

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.910

Financial Reports:

No articles found.

Tyra Biosciences, Inc.

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Actualizaciones en tiempo real para Tyra Biosciences, Inc. [TYRA]

Upcoming Earnings Alert